cTnI
cTnI

Registration Certificate No.: 京械注准20162400256


It was used to quantitatively detect troponin I in human serum in vitro.

It is used for the auxiliary diagnosis of acute myocardial infarction (AMI).


Expected Use

It was used to quantitatively detect troponin I in human serum in vitro.

It is used for the auxiliary diagnosis of acute myocardial infarction (AMI).

   

 【Testing Principle

肌钙蛋白I(cTnI)测定试剂盒(胶乳免疫比浊法)


 【Product Characteristics

Immunoturbidimetric assay has strong specificity.

Supporting calibration products and quality control products, high detection accuracy.

The reagent is stable for at least 14 days.


 【Performance Evaluation

1) linear

肌钙蛋白I(cTnI)测定试剂盒(胶乳免疫比浊法)


2) Repeatability



nx(mg/L)SDCV(%)
Serum 1202.360.156.36
Serum 1206.010.284.66


3) Stability

Original package kit: (2-8) C, valid for 12 months

The calibration curve of the reagent can be stabilized for at least 14 days.


4) Reference interval

According to the literature and the company's experimental verification, the reference interval of cTnI is < 1.69 ug/L.

Each hospital should establish its own reference range according to the actual situation in the region.

Recommend